ADVERTISEMENT
Mold-Tek Packaging Q2 Review — Inline Results, 'Buy' Maintains Axis Securities, Sees 16% Upside
Axis Securities maintains a positive outlook on Mold-Tek Packaging, driven by the rapid scale-up in the pharma segment, continued new client additions, and gradual margin improvement.
30 Oct 2025, 02:12 PM IST 
Save
Mold-Tek Packaging remains well-positioned to sustain its robust growth momentum in the coming quarters.
(Photo Source: Company website)
Mold-Tek Packaging results were broadly in line with expectations across key metrics. Revenue for Q2 FY26 stood at Rs 210 crore, registering a 10% YoY growth, supported by steady volume expansion of 6.8% YoY and an improved product mix.
